| 000 | 01831 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514162438.0 | ||
| 264 | 0 | _c20040122 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/379153 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStiefel, Usha | |
| 245 | 0 | 0 |
_aOral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cNov 2003 |
||
| 300 |
_a1605-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCandida glabrata _xgenetics |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xdrug therapy |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 |
_aDNA, Bacterial _xchemistry |
| 650 | 0 | 4 |
_aDNA, Fungal _xchemistry |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnterococcus faecium _xgenetics |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aKlebsiella Infections _xdrug therapy |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPiperacillin _xpharmacokinetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_abeta-Lactam Resistance _xdrug effects |
| 650 | 0 | 4 |
_abeta-Lactamases _xpharmacology |
| 700 | 1 | _aPultz, Nicole J | |
| 700 | 1 | _aHarmoinen, Jaana | |
| 700 | 1 | _aKoski, Pertti | |
| 700 | 1 | _aLindevall, Kai | |
| 700 | 1 | _aHelfand, Marion S | |
| 700 | 1 | _aDonskey, Curtis J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 188 _gno. 10 _gp. 1605-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/379153 _zAvailable from publisher's website |
| 999 |
_c14361113 _d14361113 |
||